Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209055 (US9266877, 1) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 425 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209057 (US9266877, 3) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209059 (US9266877, 5) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 408 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209063 (US9266877, 9) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 378 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209065 (US9266877, 11) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209066 (US9266877, 12) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 51 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209067 (US9266877, 13) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 498 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209068 (US9266877, 14) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209069 (US9266877, 15) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209071 (US9266877, 17) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209072 (US9266877, 18) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 621 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209073 (US9266877, 19) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 398 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209074 (US9266877, 20) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 13 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209075 (US9266877, 21) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209076 (US9266877, 22) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 214 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209077 (US9266877, 23) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209078 (US9266877, 24) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209079 (US9266877, 25) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 377 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209080 (US9266877, 26) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209081 (US9266877, 27) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209082 (US9266877, 28) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209083 (US9266877, 29) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209084 (US9266877, 30) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 298 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209085 (US9266877, 31) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209086 (US9266877, 32) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 216 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209087 (US9266877, 33) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209088 (US9266877, 34) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 907 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209090 (US9266877, 36) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209091 (US9266877, 37) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 347 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209092 (US9266877, 38) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209093 (US9266877, 39) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209094 (US9266877, 40) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 570 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209095 (US9266877, 41) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 11 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209096 (US9266877, 42) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 233 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209097 (US9266877, 43) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209098 (US9266877, 44) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209099 (US9266877, 45) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209100 (US9266877, 46) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209101 (US9266877, 47) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 881 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209102 (US9266877, 48) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209103 (US9266877, 49) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 12 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209104 (US9266877, 50) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209105 (US9266877, 51) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209106 (US9266877, 52) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 570 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209107 (US9266877, 53) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 387 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209108 (US9266877, 54) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 501 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209109 (US9266877, 55) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 317 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209110 (US9266877, 56) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 583 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209111 (US9266877, 57) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 741 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bcl-2-like protein 1 (Mus musculus (Mouse)) | BDBM209112 (US9266877, 58) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a |
ABBVIE INC. US Patent | Assay Description The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models... | US Patent US9266877 (2016) BindingDB Entry DOI: 10.7270/Q2H41Q7V | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 172 total ) | Next | Last >> |